AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Blood transcriptomic markers associated with immune abnormalities and sleep quality

Sang-Min Parka,1Hyo-Jeong Banb,1Minsung LeeaSoo Yeon KimbSiwoo LeebHee-Jeong Jinb( )
College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea
Korean Medicine (KM) Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work and shared the first authorship.

Show Author Information

References

1

Park SM, Park M, Ban HJ, et al. Investigation of prodromal features in metabolic syndrome based on transcriptome analysis. Genes Dis. 2022;10(3):708–711.

2

Baek Y, Seo BN, Jeong K, Yoo H, Lee S. Lifestyle, genomic types and non-communicable diseases in Korea: a protocol for the Korean Medicine Daejeon Citizen Cohort study (KDCC). BMJ Open. 2020;10(4):e034499.

3

Tumasian 3rd RA, Harish A, Kundu G, et al. Skeletal muscle transcriptome in healthy aging. Nat Commun. 2021;12(1):2014.

4

Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease. Physiol Rev. 2019;99(3):1325–1380.

Genes & Diseases
Article number: 101105
Cite this article:
Park S-M, Ban H-J, Lee M, et al. Blood transcriptomic markers associated with immune abnormalities and sleep quality. Genes & Diseases, 2024, 11(6): 101105. https://doi.org/10.1016/j.gendis.2023.101105

59

Views

2

Downloads

1

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics

Received: 20 June 2023
Published: 14 September 2023
© 2023 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Return